Measles overview: Difference between revisions

Jump to navigation Jump to search
Line 33: Line 33:


===Physical Examination===
===Physical Examination===
Measles is a condition, that is best diagnosed clinically based on a constellation of signs and symptoms. Koplik's spots, rash and conjunctivitis are 3 major physical findings that must be looked out for, while making the diagnosis of measles.  
Measles is a condition, that is best diagnosed clinically based on a constellation of signs and symptoms. Koplik's spots, rash and conjunctivitis are 3 major physical findings that must be looked out for, while making the diagnosis of measles.
 
===Laboratory Findings===
Measles is a disease best diagnosed clinically, however lab tests have a limited role to play esp. in those conditions where the diagnosis is uncertain and certain cases of atypical pneumonia. Detecting a positive rise in measles IgM antibodies is one of the methods used for laboratory diagnosis of measles. Histologially, a unique cell can be found in the paracortical region of hyperplastic lymph nodes in patients affected with pneumonia secondary to measles. This cell is known as the Warthin-Finkeldey cell. It is helpful in diagnosing measles associated pneumonia.  


===Chest X Ray===
===Chest X Ray===

Revision as of 19:03, 25 February 2014

Measles Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Measles from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Measles overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Measles overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Measles overview

CDC on Measles overview

Measles overview in the news

Blogs on Measles overview

Directions to Hospitals Treating Measles

Risk calculators and risk factors for Measles overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Measles is a disease caused by the Morbillivirus. It is transmitted into the respiratory by contact with infected fluids. Incubation lasts for 4-12 days, during which patients are asymptomatic. Symptomatic onset includes the appearance of a distinct rash. Infected people remain contagious until appearance of the first symptoms until 3-5 days after the rash appearance.

Historical Perspective

Reports of measles go as far back to at least 600 B.C. however, the first scientific description of the disease and its distinction from smallpox is attributed to the Persian physician Ibn Razi (Rhazes) 860-932 who published a book entitled "Smallpox and Measles" (in Arabic: Kitab fi al-jadari wa-al-hasbah). In 1954, the virus causing the disease was isolated from an 11-year old boy from the US, David Edmonston, and adapted and propagated on chick embryo tissue culture.[1] To date, 21 strains of the measles virus have been identified.[2] Licensed vaccines to prevent the disease became available in 1963.

Pathophysiology

Measles is a disease caused by a virus , specifically a paramyxovirus of the genus Morbillivirus.

Differentiating Measles from other Diseases

Measles is a disease characterized by the classical clinical triad of cough, coryza and conjunctivitis. In most cases the presentation is classical and the diagnosis can be sufficiently made clinically. However, in a few cases certain other diagnostic possibilities must be kept in mind. These include other viral exanthams such as erythema infectiosum, other maculopapular rashes etc. Also, in areas where killed vaccines are used, the probability of atypical measles with fever, conjunctivitis, pneumonitis and rash must be kept in mind. It is worthwhile to consider Kawasaki's disease, rubella, dengue, systemic lupus erythematosus and serum sickness while considering the diagnosis of measles.

Epidemiology and Demographics

According to the World Health Organization (WHO), measles is a leading cause of vaccine preventable childhood mortality. Worldwide, the fatality rate has been significantly reduced by partners in the Measles Initiative: the American Red Cross, the United States Centers for Disease Control and Prevention (CDC), the United Nations Foundation, UNICEF and the World Health Organization (WHO). Globally, measles deaths are down 60 percent, from an estimated 873,000 deaths in 1999 to 345,000 in 2005. Africa has seen the most success, with annual measles deaths falling by 75 percent in just 5 years, from an estimated 506,000 to 126,000.

Risk Factors

Measles is a disease with very low incidence in the developed world. Lack of vaccination against measles is one of the biggest risk factors that predisposes measles spread. In developed countries like USA, most cases are attributed to unvaccinated or incompletely vaccinated travelers from other parts of the world. Primary vaccine failure occurs in approximately 5% of individuals vaccinated with a single dose of vaccine at 12 months of age or older and also predisposes an individual to the risk of developing measles.

Natural History, Complications and Prognosis

Measles spreads through the air by breathing, coughing or sneezing. It is so contagious that any child who is exposed to it and is not immune will probably get the disease. The virus lives in the mucus in the nose and throat of the infected person. When that person sneezes or coughs, droplets spray into the air. The virus can live on infected surfaces for up to 2 hours and spreads so easily that people who are not immune will probably get it when they come close to someone who is infected. Measles is a disease of humans.

Complications with measles are relatively common, ranging from relatively mild and less serious diarrhea, to pneumonia and encephalitis (subacute sclerosing panencephalitis - SSPE). Complications are usually more severe amongst adults who catch the virus.

Measles itself is unpleasant, but the complications are dangerous. Six to 20 percent of the people who get the disease will get an ear infection, diarrhea, or even pneumonia. One out of 1000 people with measles will develop inflammation of the brain, and about one out of 1000 will die.

Diagnosis

History and Symptoms

The classical symptoms of measles include a fever for at least three days, and the three Cs—cough, coryza (runny nose) and conjunctivitis (red eyes). The fever may reach up to 104° Fahrenheit/ 40° Celsius. Koplik's spots seen inside the mouth are pathognomonic (diagnostic) for measles but are not often seen, even in real cases of measles, because they are transient and may disappear within a day of arising.

Physical Examination

Measles is a condition, that is best diagnosed clinically based on a constellation of signs and symptoms. Koplik's spots, rash and conjunctivitis are 3 major physical findings that must be looked out for, while making the diagnosis of measles.

Laboratory Findings

Measles is a disease best diagnosed clinically, however lab tests have a limited role to play esp. in those conditions where the diagnosis is uncertain and certain cases of atypical pneumonia. Detecting a positive rise in measles IgM antibodies is one of the methods used for laboratory diagnosis of measles. Histologially, a unique cell can be found in the paracortical region of hyperplastic lymph nodes in patients affected with pneumonia secondary to measles. This cell is known as the Warthin-Finkeldey cell. It is helpful in diagnosing measles associated pneumonia.

Chest X Ray

Chest X Ray can be used to diagnose pneumonia, which is one of the complications of measles. It shows consolidation of lung lobes. Damage to the alveoli may occur in severe cases leading to dyspnea.

Treatment

Medical Therapy

There is no specific treatment or antiviral therapy for uncomplicated measles. Most patients with uncomplicated measles will recover with rest and supportive treatment.

Primary Prevention

The joint press release by members of the Measles Initiative brings to light another benefit of the fight against measles: "Measles vaccination campaigns are contributing to the reduction of child deaths from other causes. They have become a channel for the delivery of other life-saving interventions, such as bed nets to protect against malaria, de-worming medicine and vitamin A supplements. Combining measles immunization with other health interventions is a contribution to the achievement of Millennium Development Goal Number 4: a two-thirds reduction in child deaths between 1990 and 2015."[3]

References

  1. Live attenuated measles vaccine. EPI Newsl. 1980 Feb;2(1):6.
  2. Rima BK, Earle JA, Yeo RP, Herlihy L, Baczko K, ter Muelen V, Carabana J, Caballero M, Celma ML, Fernandez-Munoz R 1995 Temporal and geographical distribution of measles virus genotypes. J Gen Virol 76:11731180.
  3. UNICEF Joint Press Release

Template:WH Template:WS